User profiles for "author:Richard Sullivan"

Prof Richard Sullivan

Kings Health Partners
Verified email at doctors.org.uk
Cited by 31315

Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development

JG Meara, AJM Leather, L Hagander, BC Alkire… - The lancet, 2015 - thelancet.com
Executive summary Remarkable gains have been made in global health in the past 25
years, but progress has not been uniform. Mortality and morbidity from common conditions …

The global burden of women's cancers: a grand challenge in global health

O Ginsburg, F Bray, MP Coleman, V Vanderpuye… - The Lancet, 2017 - thelancet.com
Every year, more than 2 million women worldwide are diagnosed with breast or cervical
cancer, yet where a woman lives, her socioeconomic status, and agency largely determines …

Mortality due to cancer treatment delay: systematic review and meta-analysis

TP Hanna, WD King, S Thibodeau, M Jalink, GA Paulin… - bmj, 2020 - bmj.com
Objective To quantify the association of cancer treatment delay and mortality for each four
week increase in delay to inform cancer treatment pathways. Design Systematic review and …

[HTML][HTML] The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

C Maringe, J Spicer, M Morris, A Purushotham… - The lancet …, 2020 - thelancet.com
Background Since a national lockdown was introduced across the UK in March, 2020, in
response to the COVID-19 pandemic, cancer screening has been suspended, routine …

The burden of disease in older people and implications for health policy and practice

MJ Prince, F Wu, Y Guo, LMG Robledo, M O'Donnell… - The lancet, 2015 - thelancet.com
Summary 23% of the total global burden of disease is attributable to disorders in people
aged 60 years and older. Although the proportion of the burden arising from older people (≥ …

Oxygen-induced retinopathy in the mouse.

LE Smith, E Wesolowski, A McLellan… - … & visual science, 1994 - iovs.arvojournals.org
PURPOSE: To develop oxygen-induced retinopathy in the mouse with reproducible and
quantifiable proliferative retinal neovascularization suitable for examining pathogenesis and …

Economic burden of cancer across the European Union: a population-based cost analysis

R Luengo-Fernandez, J Leal, A Gray… - The lancet oncology, 2013 - thelancet.com
Summary Background In 2008, 2· 45 million people were diagnosed with cancer and 1· 23
million died because of cancer in the 27 countries of the European Union (EU). We aimed to …

[HTML][HTML] Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer… - The Lancet …, 2021 - thelancet.com
Background Surgery is the main modality of cure for solid cancers and was prioritised to
continue during COVID-19 outbreaks. This study aimed to identify immediate areas for …

[HTML][HTML] A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European …

NI Cherny, R Sullivan, U Dafni, JM Kerst, A Sobrero… - Annals of …, 2015 - Elsevier
The value of any new therapeutic strategy or treatment is determined by the magnitude of its
clinical benefit balanced against its cost. Evidence for clinical benefit from new treatment …

Delivering affordable cancer care in high-income countries

R Sullivan, J Peppercorn, K Sikora, J Zalcberg… - The lancet …, 2011 - thelancet.com
The burden of cancer is growing, and the disease is becoming a major economic
expenditure for all developed countries. In 2008, the worldwide cost of cancer due to …